United States securities and exchange commission logo
June 12, 2023
Andrew Freedman
Partner
Olshan Frome Wolosky LLP
1325 Avenue of the Americas
New York, New York 10019
Re: Diversified
Healthcare Trust
PREC14A filed June
7, 2023
Filed by Flat
Footed LLC and Marc Andersen
SEC File No.
001-15319
Dear Andrew Freedman:
We have reviewed your filing and have the following comments. In
some of our
comments, we may ask you to provide us with information so we may better
understand your
disclosure.
Please respond to these comments by providing the requested
information or advise us as
soon as possible when you will respond. If you do not believe our
comments apply to your facts
and circumstances, please tell us why in your response.
After reviewing your response to these comments, we may have
additional comments.
All defined terms used here have the same meaning as in your proxy
statement.
PREC14A filed June 7, 2023
Consequences of Defeating the DHC Merger Proposals, page 12
1. In the last paragraph
on page 8, modify the statement that the foregoing description is "not
complete." A summary is
necessarily more condensed than the entire merger agreement
but should describe its
material terms.
Additional Participant Information, page 18
2. To the extent that
these participants have interests in the solicitation beyond share
ownership in DHC,
please revise to describe and to explain how defeating the merger
proposals will or may
affect them. See Item 5(b)(i) of Schedule 14A.
Andrew Freedman
Olshan Frome Wolosky LLP
June 12, 2023
Page 2
General
3. Please ensure that all statements of opinion or belief in the proxy
statement are
characterized as such, and supported by a reasonable factual basis
included in the proxy
statement. Some (non-exhaustive) examples of beliefs which are not
characterized as
such and should be revised and supported include the following:
- "This cements the complete lack of financial rationale for the
transaction, other than
enriching RMR, OPI and company advisors" (page 8);
- "This is an incredibly high fee burden for a merger of this size"
(page 8); and
- "The Merger Proxy Statement confirms the proposed Merger undervalues
DHC" (page
9).
Revise generally, including to provide the basis for statements
recharacterized as beliefs
and other assertions of fact found in this section of the proxy
statement.
We remind you that the filing persons are responsible for the accuracy
and adequacy of
their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please direct any questions to Christina Chalk at (202) 551-3263.
FirstName LastNameAndrew Freedman Sincerely,
Comapany NameOlshan Frome Wolosky LLP
Division of
Corporation Finance
June 12, 2023 Page 2 Office of
Mergers & Acquisitions
FirstName LastName